market should align manufacturing, packaging, labeling, and holding practices with 21 CFR Part 111 cGMP expectations
They should not displace correction of sleep, nutrition, mineral balance, metabolic disease, oxidative burden and medication-related factors.
It is not intended for human or veterinary use, diagnosis, treatment, prevention of disease, or consumption
Published on November 2nd, 2023
Although macrolides (e.g
In vivo studies in rodents have consistently shown improved neovascularization or angiogenesis along with accelerated wound closure due to enhanced re-epithelialization and collagen deposition